CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822082553
- Phone
- (781) 222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $654,036
- in 3 filings
Net −$654,036. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-01 | Peeples-Dyer Veleka Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2025-04-01 | Patel Sushil Chief Executive Officer | Grant or award | +166,667 | 368,681 | ||
| 2025-04-01 | Patel Sushil Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2025-04-01 | Pucci Paolo Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2025-04-01 | Balachandran Madhavan Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2025-04-01 | Xynos Konstantinos Chief Medical Officer | Grant or award | +45,000 | 154,885 | ||
| 2025-04-01 | Xynos Konstantinos Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2025-04-01 | Dhingra Kapil Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2025-04-01 | SLATTERY JOSEPH P Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2025-04-01 | Hill Emily Luisa Chief Financial Officer | Grant or award | +45,000 | 146,057 | ||
| 2025-04-01 | Hill Emily Luisa Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2025-04-01 | Weinand Dieter Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2025-04-01 | Sarchi Christopher Chief Commercial Officer | Grant or award | +45,000 | 132,045 | ||
| 2025-04-01 | Sarchi Christopher Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +67,500 | 67,500 | ||
| 2025-04-01 | Oliger Christy J. Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2025-04-01 | Schwendenman Andrew Chief Accounting Officer | Grant or award | −33,333 | 71,571 | ||
| 2025-04-01 | Schwendenman Andrew Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-03-05 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy)uy) | +64,000 | 64,000 | ||
| 2025-03-05 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Option (right to buy)uy) | +64,000 | 64,000 | ||
| 2024-12-16 | Patel Sushil Chief Executive Officer | Sale 10b5-1 | −10,000 | $12.42 | $124K | 202,014 |
Page 4 of 8 · 143 trades